Role of the Cytochrome P450 Enzyme System in Veterinary Pharmacokinetics: Where are We Now? Where are We Going?

• US FDA Guidance for Industry . Target Animal Safety for Veterinary Pharmaceutical Products, VICH GL43 (2010)
   Google Scholar
• Rushmore TH , KongAN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.Curr. Drug Metab.3(5), 481–490 (2002).
   PubMed Web of Science ®Google Scholar
• Sallustio BC , SabordoL, EvansAM, NationRL. Hepatic disposition of electrophilic acyl glucuronide conjugates.Curr. Drug Metab.1(2), 163–180 (2000).
   PubMed Web of Science ®Google Scholar
• Glatt H . Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation.FASEB J.11(5), 314–321 (1997).
   PubMed Web of Science ®Google Scholar
• Coleman M . Human Drug Metabolism: An Introduction. John Wiley & Sons Ltd, NY, USA (2005).
   Google Scholar
• Brodie BB , GilletteJR, La Du BN. Enzymatic metabolism of drugs and other foreign compounds. Annu. Rev. Biochem.27(3), 427–454 (1958).
   PubMedGoogle Scholar
• Omura T , SatoR. A new cytochrome in liver microsomes.J. Biol. Chem.237, 1375–1376 (1962).
   PubMed Web of Science ®Google Scholar
• Omura T . Structural diversity of cytochrome P450 enzyme system.J. Biochem.147(3), 297–306 (2010).
   PubMed Web of Science ®Google Scholar
• Neve EP , Ingelman-SundbergM. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.Curr. Opin. Drug Discov. Devel.13(1), 78–85 (2010).
   PubMedGoogle Scholar
• Ioannides C . Cytochrome p450 expression in the liver of food-producing animals.Curr. Drug Metab.7(4), 335–348 (2006).
   PubMed Web of Science ®Google Scholar
• Graham MJ , LakeBG. Induction of drug metabolism: species differences and toxicological relevance.Toxicology254(3), 184–191 (2008).
   PubMed Web of Science ®Google Scholar
• Singh SS . Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.Curr. Drug Metab.7(2), 165–182 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson DR . The cytochrome p450 homepage.Hum. Genomics4(1), 59–65 (2009).
   PubMedGoogle Scholar
• Eddy SR . A new generation of homology search tools based on probabilistic inference.Genome Inform.23(1), 205–211 (2009).
   PubMedGoogle Scholar
• Ortiz de Montellano PR . Cytochrome P450: Structure, Mechanism, and Biochemistry. Kluwer Academic/Plenum Publishers, NY, USA (2005)
   Google Scholar
• Larhammar D , SundstromG, DreborgS, DazaDO, LarssonTA. Major genomic events and their consequences for vertebrate evolution and endocrinology.Ann. NY Acad. Sci.1163, 201–208 (2009).
   PubMed Web of Science ®Google Scholar
• Nebbia C , DacastoM, RossettoGA, GiulianoAA, CarlettiM. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species.Vet. J.165(1), 53–64 (2003).
   PubMed Web of Science ®Google Scholar
• Mise M , HashizumeT, KomuroS. Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes.Drug Metab. Dispos.36(9), 1903–1908 (2008).
   PubMed Web of Science ®Google Scholar
• Fink-Gremmels J . Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences.Eur. J. Pharmacol.585(2–3), 502–509 (2008).
   PubMed Web of Science ®Google Scholar
• Kamimura H . Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations.Arch. Toxicol.80(11), 732–738 (2006).
   PubMed Web of Science ®Google Scholar
• Martignoni M , GroothuisGM. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.Expert Opin. Drug Metab. Toxicol.2(6), 875–894 (2006).
   PubMed Web of Science ®Google Scholar
• Rawal S , YipSS, CoulombeRA, Jr. Cloning, expression and functional characterization of cytochrome P450 3A37 from turkey liver with high aflatoxin B1 epoxidation activity. Chem. Res. Toxicol.23(8), 1322–1329 (2010).
   PubMed Web of Science ®Google Scholar
• Sharer JE , ShipleyLA, VandenbrandenMR, BinkleySN, WrightonSA. Comparisons of Phase I and Phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab. Dispos.23(11), 1231–1241 (1995).
   PubMed Web of Science ®Google Scholar
• Komatsu T , HondaK, KubotaA, KitazawaT, HiragaT, TeraokaH. Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats.J. Vet. Med. Sci.72(12), 1633–1636 (2010).
   PubMed Web of Science ®Google Scholar
• Shah SS , SandaS, RegmiNL, SasakiK, ShimodaM. Characterization of cytochrome P450-mediated drug metabolism in cats.J. Vet. Pharmacol. Ther.30(5), 422–428 (2007).
   PubMed Web of Science ®Google Scholar
• Tanaka N , ShinkyoR, SakakiTet al. Cytochrome P450 2E polymorphism in feline liver. Biochim. Biophys. Acta 1726(2), 194–205 (2005).
   PubMed Web of Science ®Google Scholar
• Tanaka N , MiyashoT, ShinkyoR, SakakiT, YokotaH. cDNA cloning and characterization of feline CYP1A1 and CYP1A2.Life Sci.79(26), 2463–2473 (2006).
   PubMed Web of Science ®Google Scholar
• van Beusekom CD , SchipperL, Fink-GremmelsJ. Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs.J. Vet. Pharmacol. Ther.33(6), 519–527 (2010).
   PubMed Web of Science ®Google Scholar
• Lewis DF , EddershawPJ, DickinsM, TarbitMH, GoldfarbPS. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate.Chem. Biol. Interact.115(3), 175–199 (1998).
   PubMed Web of Science ®Google Scholar
• Fleischer S , SharkeyM, MealeyK, OstranderEA, MartinezM. Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.AAPS. J.10(1), 110–119 (2008).
   PubMed Web of Science ®Google Scholar
• Martinez M , ModricS. Patient variation in veterinary medicine: part I. Influence of altered physiological states.J. Vet. Pharmacol. Ther.33(3), 213–226 (2010).
   PubMed Web of Science ®Google Scholar
• Modric S , MartinezM. Patient variation in veterinary medicine: part II. Influence of physiological variables.J. Vet. Pharmacol. Ther.34(3), 209–223 (2011).
   PubMed Web of Science ®Google Scholar
• Daly AK . Pharmacogenetics and human genetic polymorphisms.Biochem. J.429(3), 435–449 (2010).
   PubMedGoogle Scholar
• Jover R , MoyaM, Gomez-LechonMJ. Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha.Curr. Drug Metab.10(5), 508–519 (2009).
   PubMed Web of Science ®Google Scholar
• Gomez A , Ingelman-SundbergM. Pharmacoepigenetics: its role in interindividual differences in drug response.Clin. Pharmacol. Ther.85(4), 426–430 (2009).
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M , SimSC, GomezA, Rodriguez-AntonaC. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.Pharmacol. Ther.116(3), 496–526 (2007).
   PubMed Web of Science ®Google Scholar
• Chen SH , ZhaoriG. Potential clinical applications of siRNA technique: benefits and limitations.Eur. J. Clin. Invest.1–12 (2010).
   Web of Science ®Google Scholar
• Lee JI , ZhangL, MenAY, KennaLA, HuangSM. CYP-mediated therapeutic protein–drug interactions: clinical findings, proposed mechanisms and regulatory implications.Clin. Pharmacokinet.49(5), 295–310 (2010).
   PubMed Web of Science ®Google Scholar
• Watkins PB , WrightonSA, SchuetzEG, MaurelP, GuzelianPS. Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture.J. Biol. Chem.261(14), 6264–6271 (1986).
   PubMed Web of Science ®Google Scholar
• Zhu BT . On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations.Expert Opin. Drug Metab. Toxicol.6(4), 483–494 (2010).
   PubMed Web of Science ®Google Scholar
• Dickins M . Induction of cytochromes P450.Curr. Top. Med. Chem.4(16), 1745–1766 (2004).
   PubMed Web of Science ®Google Scholar
• Hakkola J , PasanenM, PelkonenOet al. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18(2), 391–397 (1997).
   PubMed Web of Science ®Google Scholar
• Roussel F , DuignanDB, LawtonMP, ObachRS, StrickCA, TweedieDJ. Expression and characterization of canine cytochrome P450 2D15.Arch. Biochem. Biophys.357(1), 27–36 (1998).
   PubMed Web of Science ®Google Scholar
• Flockhart DA . Drug interactions: cytochrome P450 drug interaction table. Indiana University School of Medicine (2007).
   Google Scholar
• Ingelman-Sundberg M , SimSC. Intronic polymorphisms of cytochromes P450.Hum. Genomics4(6), 402–405 (2010).
   PubMedGoogle Scholar
• Giorgi MA , DiGG, GonzalezCD. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.Expert Opin. Pharmacother.11(14), 2391–2403 (2010).
   PubMed Web of Science ®Google Scholar
• Gladding P , WebsterM, ZengIet al. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial. JACC Cardiovasc. Interv. 1(6), 620–627 (2008).
   PubMed Web of Science ®Google Scholar
• Sangkuhl K , KleinTE, AltmanRB. Clopidogrel pathway.Pharmacogenet. Genomics20(7), 463–465 (2010).
   PubMed Web of Science ®Google Scholar
• Solus JF , AriettaBJ, HarrisJRet al. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 5(7), 895–931 (2004).
   PubMed Web of Science ®Google Scholar
• Zhou SF , LiuJP, ChowbayB. Polymorphism of human cytochrome P450 enzymes and its clinical impact.Drug Metab. Rev.41(2), 89–295 (2009).
   PubMed Web of Science ®Google Scholar
• Squires EJ , LundstromK. Relationship between cytochrome P450IIE1 in liver and levels of skatole and its metabolites in intact male pigs.J. Anim. Sci.75(9), 2506–2511 (1997).
   PubMed Web of Science ®Google Scholar
• Moe M , LienS, AasmundstadTet al. Association between SNPs within candidate genes and compounds related to boar taint and reproduction. BMC Genet. 10, 32 (2009).
   PubMed Web of Science ®Google Scholar
• Bendixen E , DanielsenM, LarsenK, BendixenC. Advances in porcine genomics and proteomics – a toolbox for developing the pig as a model organism for molecular biomedical research.Brief Funct. Genomics9(3), 208–219 (2010).
   PubMed Web of Science ®Google Scholar
• van der Laan JW , BrightwellJ, McAnultyP, RatkyJ, StarkC. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.J. Pharmacol. Toxicol. Methods62(3), 184–195 (2010).
   PubMed Web of Science ®Google Scholar
• Ekser B , RigottiP, GridelliB, CooperDK. Xenotransplantation of solid organs in the pig-to-primate model.Transpl. Immunol.21(2), 87–92 (2009).
   PubMed Web of Science ®Google Scholar
• Witkamp R , MonshouwerM. Pharmacokinetic in vivo and in vitro in swine. Scand. J. Lab. Anim. Sci.25(Suppl. 1), 45–56 (1998).
   Google Scholar
• Kishida T , MutoS, HayashiMet al. Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague-Dawley and Wistar rats. J. Toxicol. Sci. 33(4), 447–457 (2008).
   PubMed Web of Science ®Google Scholar
• Dacasto M , EeckhoutteC, CapolongoaFet al. Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants. Vet. Res. 36(2), 179–190 (2005).
   PubMed Web of Science ®Google Scholar
• Depelchin BO , BlodenS, MichauxC, AnsayM. Effects of age, sex and breed on antipyrine disposition in calves.Res. Vet. Sci.44(2), 135–139 (1988).
   PubMed Web of Science ®Google Scholar
• Goriya HV , KaliaA, BhavsarSK, JoshiCG, RankDN, ThakerAM. Comparative evaluation of phenobarbital-induced CYP3A and CYP2H1 gene expression by quantitative RT-PCR in Bantam, Bantamized White Leghorn and White Leghorn chicks.J. Vet. Sci.6(4), 279–285 (2005).
   PubMedGoogle Scholar
• Mise M , YaderaS, MatsudaMet al. Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs. Drug Metab. Dispos. 32(2), 240–245 (2004).
   PubMed Web of Science ®Google Scholar
• Mise M , HashizumeT, MatsumotoS, TerauchiY, FujiiT. Identification of non-functional allelic variant of CYP1A2 in dogs.Pharmacogenetics14(11), 769–773 (2004).
   PubMedGoogle Scholar
• Tenmizu D , EndoY, NoguchiK, KamimuraH. Identification of the novel canine CYP1A2 1117 C > T SNP causing protein deletion.Xenobiotica34(9), 835–846 (2004).
   PubMed Web of Science ®Google Scholar
• Blaisdell J , GoldsteinJA, BaiSA. Isolation of a new canine cytochrome P450 cDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression.Drug Metab. Dispos.26(3), 278–283 (1998).
   PubMed Web of Science ®Google Scholar
• Paulson SK , EngelL, ReitzBet al. Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab. Dispos. 27(10), 1133–1142 (1999).
   PubMed Web of Science ®Google Scholar
• de Zwart LL , HaenenHEMG, VersantvoortCHM, SipsAJAM. Pharmacokinetics of ingested xenobiotics in children: a comparison with adults. RIVM Report no. 623860011. National Institute for Public Health and the Environment, Bilthoven, The Netherlands (2002).
   Google Scholar
• Clewell HJ , TeeguardenJ, McDonaldTet al. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Crit. Rev. Toxicol. 32(5), 329–389 (2002).
   PubMed Web of Science ®Google Scholar
• Hines RN , McCarverDG. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes.J. Pharmacol. Exp. Ther.300(2), 355–360 (2002).
   PubMed Web of Science ®Google Scholar
• Tanaka E , NarisawaC, NakamuraHet al. Changes in the enzymatic activities of beagle liver during maturation as assessed both in vitro and in vivo. Xenobiotica 28(8), 795–802 (1998).
   PubMed Web of Science ®Google Scholar
• Virkel G , CarlettiM, CantielloMet al. Characterization of xenobiotic metabolizing enzymes in bovine small intestinal mucosa. J. Vet. Pharmacol. Ther. 33(3), 295–303 (2010).
   PubMed Web of Science ®Google Scholar
• Baillie TA . Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology.Chem. Res. Toxicol.19(7), 889–893 (2006).
   PubMed Web of Science ®Google Scholar
• Sun H , ScottDO. Structure-based drug metabolism predictions for drug design.Chem. Biol. Drug Des.75(1), 3–17 (2010).
   PubMed Web of Science ®Google Scholar
• Smith DA , ObachRS. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.Chem. Res. Toxicol.22(2), 267–279 (2009).
   PubMed Web of Science ®Google Scholar
• Zareba W . Drug induced QT prolongation.Cardiol. J.14(6), 523–533 (2007).
   PubMedGoogle Scholar
• Diaz GJ , MurciaHW, CepedaSM. Cytochrome P450 enzymes involved in the metabolism of aflatoxin B1 in chickens and quail.Poult. Sci.89(11), 2461–2469 (2010).
   PubMed Web of Science ®Google Scholar
• Szucs G , TamasiV, LaczayP, MonostoryK. Biochemical background of toxic interaction between tiamulin and monensin.Chem. Biol. Interact.147(2), 151–161 (2004).
   PubMed Web of Science ®Google Scholar
• Cullen LK . Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose.Br. Vet. J.152(5), 519–535 (1996).
   PubMedGoogle Scholar
• Baratta MT , ZayaMJ, WhiteJA, LocusonCW. Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs.J. Vet. Pharmacol. Ther.33(1), 50–55 (2010).
   PubMed Web of Science ®Google Scholar
• Mills BM , ZayaMJ, WaltersRRet al. Current cytochrome P450 phenotyping methods applied to metabolic drug–drug interaction prediction in dogs. Drug Metab Dispos. 38(3), 396–404 (2010).
   PubMed Web of Science ®Google Scholar
• A Handbook of Bioanalysis and Drug Metabolism . EvansG (Ed.). CRC Press, NY, USA (2004)
   Google Scholar
• Cytochrome P450 Protocols . PhilipsIR, ShephardEA (Eds.). Humana Press, NY, USA (2006)
   Google Scholar
• Drug Metabolism in Drug Design and Development . ZhangD, ZhuM, HumphreyG (Eds). Wiley, NY, USA (2007)
   Google Scholar
• Reddy M , YangRS, AndersonME, ClewellHJ. Physiologically Based Pharmacokinetic Modeling: Science and Applications. John Wiley & Sons, NY, USA (2011)
   Google Scholar
• Rowland M , PeckC, TuckerG. Physiologically-based pharmacokinetics in drug development and regulatory science.Annu. Rev. Pharmacol. Toxicol.51, 45–73 (2011).
   PubMed Web of Science ®Google Scholar
• Zhao P , ZhangL, GrilloJAet al. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin. Pharmacol. Ther. 89(2), 259–267 (2010).
   PubMed Web of Science ®Google Scholar
• Ulveling D , FrancastelC, HubeF. When one is better than two: RNA with dual functions.Biochimie1–12 (2010).
   PubMed Web of Science ®Google Scholar

Websites

• The human cytochrome P450 (CYP) allele nomenclature committee www.cypalleles.ki.se
   Google Scholar
• BLAST assembled RefSeq genomes www.ncbi.nlm.nih.gov/BLAST
   Google Scholar
• Cytochrome P450 homepage http://drnelson.uthsc.edu/cytochromeP450.html
   Google Scholar
• GenBank overview www.ncbi.nlm.nih.gov/Genbank/
   Google Scholar
• Directory of P450-containing systems www.icgeb.org/∼p450srv/
   Google Scholar
• Human (Homo sapiens) genome browser gateway http://genome.ucsc.edu/cgi-bin/hgGateway
   Google Scholar
• P450 drug interaction table http://medicine.iupui.edu/clinpharm/ddis/table.asp
   Google Scholar
• Valnemulin: reintroduction medicated feed premix for swine dysentery and enzootic pneumonia www.octagon-services.co.uk/articles/econor.htm
   Google Scholar
• Novartis completes extensive investigation of mysterious adverse drug reactions www.econor.com/newsroom/en_hp/back003.shtml
   Google Scholar
• International Centre for Genetic Engineering and Biotechnology. Age-dependent changes in liver microsomal cytochrome P-450. www.icgeb.org/∼p450srv/P450_ageing.html
   Google Scholar
• Animal Pharmaceutics & Technology Focus Group www.aaps.org/inside/focus_groups/Animal/index.asp
   Google Scholar
• Sanofi-aventis. Plavix® prescribing information http://products.sanofi-aventis.us/plavix/plavix.htm
   Google Scholar